Hello! Welcome to the official website of Betta Pharmaceuticals!
Service Hotline:+86-571-86130357
Add to Favorites
|
Online Feedback
简
|
繁
|
EN
Home
|
About
|
Product
|
New Drug
|
Dream Works
|
Investor
|
Talent
|
Contact
Adhering to an innovative development philosophy to benefit the people, Betta Pharmaceuticals commits to the new drug development to achieve scientific innovation for the people, create more affordable medicines, and make people live better.
· Company Profile
· Management Team
· Awards & Recognition
· Culture
· Icotinib
· Ensartinib
· R&D
· Pipeline
· Partner
· Park
·Core Strengths
· A-shares
· H-shares
· Recruitment
· Campus
· Contact
Investor / H-shares / Corporate Regulation
Company
Governance
Announcement
Prospectus
Contact
Home
>
Investor
>
H-shares
>
Corporate Regulation
Company Policy
Company Policy
Articles of Association
Board of Directors
Executive Director
Dr. Ding Lieming (Chairman)
Mr. Wan Jiang
Dr. Wang Jiabing
Ms. Tong Jia
Independent Non-executive Director
Dr. Yi Shi
Mr. Yu Zhihua
Dr. Cai Jiangnan
Dr. Jun Zhao
Dr. Wang Wei
Ms. Huang Xinqi
Strategic Investment Committee
Dr. Ding Lieming (Chairman)
Mr. Wan Jiang
Dr. Wang Jiabing
Ms. Tong Jia
The Audit Committee
Ms. Huang Xinqi (Chairman)
Mr. Yu Zhihua
Dr. Wang Wei
Dr. Jun Zhao
Compensation and Evaluation Committee
Dr. Cai Jiangnan (Chairman)
Dr. Yi Shi
Ms. Huang Xinqi
Dr. Wang Wei
Nomination Committee
Dr. Zhao Jun (Chairman)
Dr. Ding Lieming
Dr. Cai Jiangnan
Senior Management
Chairman and Chief Executive Officer
Dr. Ding Lieming
Senior Vice President and Chief Operations Officer
Mr. Wan Jiang
Senior Vice President and Chief Scientific Officer
Dr. Wang Jiabing
Chief Administrative Officer
Ms. Tong Jia
Vice President and Chief Financial Officer
Mr. Fan Jianxun
Assistant to the Chairman and Secretary of the Board
Mr. Wu Lingxi
Copyright © 2019 All Rights Reserved Betta Pharmaceuticals Co., Ltd.
浙ICP备11052940号-2
Site Map
|
Copyright
|
Feedback
|
Enterprise E-Mail
|
OA Login